comparemela.com

Omeros Co. (NASDAQ:OMER – Free Report) – Equities researchers at Cantor Fitzgerald cut their FY2024 EPS estimates for Omeros in a research report issued on Thursday, May 16th. Cantor Fitzgerald analyst O. Brayer now anticipates that the biopharmaceutical company will post earnings per share of ($1.81) for the year, down from their previous forecast of […]

Related Keywords

,Cerity Partners ,Needham Company ,Omeros Co ,Cantor Fitzgerald ,Nasdaq ,Omeros Corporation ,Ancora Advisors ,Barclays Plc ,Empirical Financial Services ,Sg Americas Securities ,Free Report ,Get Free Report ,Empirical Wealth Management ,Financial Services ,Omeros Daily ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.